Skip to content
Gut Metabolic
Prescription GLP-1 · price transparency review
68/100

MadeMed review

MadeMed is IDL Health LLC of Houston, trading with medical services through Xpedicare, LLC, selling compounded semaglutide and tirzepatide as weekly injections or sublingual tablets — four products, two named pharmacies, a full price ladder returned by its own public API, and not one month-to-month plan anywhere in it: the shortest thing it sells is a quarterly prepay of $717 or $1,197.

MadeMed publishes its price before the medical intake — you can see what it costs without handing over your health history first.

On this page
Semaglutide
$239/mo on the shortest plan it sells (compounded weekly injection its page describes as enhanced with L-carnitine, billed $717 up front every 3 months; no month-to-month rung exists — $199/mo needs 6 months at $1,194 up front, and a vial ships every 2 months against a 3-month billing cycle)
Tirzepatide
$399/mo on the shortest plan it sells (compounded weekly injection its pharmacy title records as tirzepatide/methylcobalamin — B12 — though its own marketing page says L-carnitine; billed $1,197 up front every 3 months; no month-to-month rung — $369/mo needs 6 months at $2,214 up front)
Coverage
Not published for its GLP-1 line — the only coverage it publishes is 23 states, and that is for NAD+
Price visible
Before intake

The verdict

MadeMed does print a price before the medical intake, and then most of what that earns is spent again: the advertised figure needs conditions the headline does not carry, or the seller's own documents do not stand behind it. It lands at 26 of 31.

The number beside MadeMed's name answers one question — can you find out what this costs before you hand over your medical history? — and it is dominated by that. A program is credited for naming the pharmacies that compound its medicine and for a certification whose seal actually resolves, and docked when the advertised rate needs a commitment, when a second fee sits outside it, when the seller's own terms say the published figure is not what it will charge, and when the FDA has a warning letter on file. What the price turns out to be is not an input at all, which is why a cheaper program can sit below a dearer one here.

Who it is for, and who it is not

A good fit if

  • You want to compare before you hand anything over

    MadeMed publishes what it charges before the medical intake, so you can weigh it against anything else on this page without first giving a company your health history.

  • You want to know who makes the medicine

    It names Precision, AbsoluteRX publicly. A compounded medicine is only as good as the pharmacy that made it, and a company willing to name one is a company you can go and check.

Look elsewhere if

  • You do not want to read the small print

    Its advertised figure needs conditions the headline does not carry. The full price note on this page is long for that reason, and skimming it is how people end up on a plan they did not think they were buying.

What it actually costs

Both figures below are reproduced exactly as we recorded them, with every condition attached. They are long on purpose: a monthly rate quoted without the term that buys it, the cadence it is billed on, or the dose it applies to is the single most common way a price on a page like this turns out to be untrue.

Semaglutide

$239/mo on the shortest plan it sells (compounded weekly injection its page describes as enhanced with L-carnitine, billed $717 up front every 3 months; no month-to-month rung exists — $199/mo needs 6 months at $1,194 up front, and a vial ships every 2 months against a 3-month billing cycle)

Tirzepatide

$399/mo on the shortest plan it sells (compounded weekly injection its pharmacy title records as tirzepatide/methylcobalamin — B12 — though its own marketing page says L-carnitine; billed $1,197 up front every 3 months; no month-to-month rung — $369/mo needs 6 months at $2,214 up front)

Where it operates

Not published for its GLP-1 line — the only coverage it publishes is 23 states, and that is for NAD+

Check MadeMed pricing

MadeMed pays us a commission if you start care through this link — as does every company with a review here, which is what decides who gets one, so this is not a survey of the market. See our disclosure, and weigh the trade-offs above against the evidence rather than taking our word for it. MadeMed sells a prescription medicine, not a probiotic; this site's ranked shelf is the metabolic probiotic ranking, and a supplement is a different decision from a drug.

The pharmacy behind the medicine

It names its pharmacy. MadeMed discloses Precision, AbsoluteRX as its compounding partners. That matters more here than the price does: a compounded medicine is only as good as the pharmacy that made it, and a company willing to name one is a company you can go and check.

A compounded drug is mixed to order by a pharmacy rather than manufactured and released as a finished product, so the FDA has not reviewed the specific preparation you are prescribed for safety, effectiveness or quality. That is true of every compounded program on this page, including the ones that score highest, and it is the most important sentence on it.

The honest read

What it does well

  • Its own public product API returns the full ladder for every product before any intake — pharmacy, SKU, dosage, term and total — so the price is not merely advertised, it is inspectable
  • Names the compounding pharmacies that fill each route: Precision for the injectables, AbsoluteRX for the sublingual tablets
  • Both molecules in both routes — injectable and sublingual semaglutide and tirzepatide — which is more format choice than most compounded programs on this page offer
  • Cancellation is genuinely well built: a seven-day pre-charge email that names the amount, one-click cancellation, and a pause that stops billing immediately
  • Publishes a customer support telephone number (1-800-582-1428) rather than routing everything through chat

What to check first

  • There is no month-to-month plan at any price. Every product but tadalafil returns zero for its monthly, yearly and one-time price, so the smallest purchase is a quarterly prepay: $717 of injectable semaglutide or $1,197 of injectable tirzepatide, charged in one go
  • Every "From $X/mo" on its heroes and its treatments grid is the SIX-month rung — "From $199/mo" semaglutide is $1,194 up front — and the tadalafil headline of "From $49/mo" is the twelve-month rung against a true monthly of $119
  • It prints "LegitScript Verified" as static text on its NAD+ page, but the badge is a self-hosted image with no seal id behind it, so there is nothing a reader can check and nothing we could probe. We do not repeat the claim
  • The only clinician it names anywhere is a pharmacist — Dr. Christine Folake Coon, PharmD, its "Chief Medical Reviewer", whose NPI 1528496296 does resolve — while its product pages promise a board-certified physician consultation. No prescribing physician is named
  • It publishes no state list for its GLP-1 line at all. The only coverage figure on the site is 23 states, and that is for NAD+
  • Its longevity line requires lab work before prescribing — a CMP before NAD+, an IGF-1 baseline before sermorelin — that is not included in the plan price and is not priced anywhere, and its returns policy refers to a "medical consultation fee" it never prices either
  • The "club member" tier in its own API is priced identically to the non-member tier on every single product, so the membership currently discounts nothing
  • Its NAD+ FAQ sells a 500 mg starter dose and says many customers begin there; its catalog stocks only the 1000 mg. A dose purchasable at no tier is not a dose you can buy
  • We could not complete the pharmacy screen: it credits "Precision", a first name with no legal entity published anywhere, so there is no full name to check an index against
  • No prorated refunds, all prescription and OTC sales final, consultation fees non-refundable, liability capped at $500, arbitration under Texas law
  • Compounded semaglutide and tirzepatide are not FDA-approved products and are not generic equivalents of Ozempic, Wegovy or Zepbound, none of which it sells
  • Compounded medications are not FDA-approved finished products

How it compares

MadeMed sits at 26 of 31 on this page. Every prescription GLP-1 program this site links out to is scored on the same question: can you see the price before you hand over your health history? The full list is on the prescription GLP-1 review index.

Because MadeMed prints a figure before the intake rather than after it, it is also a ranked row on our GLP-1 telehealth ranking, our compounded semaglutide ranking and our compounded tirzepatide ranking. Each is this same question narrowed to the programs that answer it, with every figure printed as we recorded it and its conditions attached rather than trimmed to fit a column.

  • Strut Health review

    From $99/mo (compounded oral)

  • Direct Meds review

    From $249/mo (compounded oral)

  • WellMedr review
    $99 per cycle month-to-month — but a plan it calls "1 Month Supply" bills every 21 DAYS, which is 17.38 charges a year and $143/calendar month, not $99; the $59/mo on its card is the 12-month rung ($708 every 350 days)Show the full pricing note
  • Eden review
    $99/mo all-inclusive on the page our link opens (compounded weekly injection, flat at every dose, "no membership fees" and a lifetime price guarantee — while eden.health's own weight-loss page sells the same molecule at $99 medication-only plus a mandatory $99/mo membership, $198/mo all-in)Show the full pricing note
  • MyDrHank review

    $249/mo month-to-month (compounded oral; $171 only on a 12-month prepay)

Read this before you start

Checked on MadeMed's own site on . Prices change — confirm on MadeMed's own site before you commit. This page is informational and not medical advice: a GLP-1 is a prescription drug, and whether one suits you is a decision for a licensed clinician who knows your history. How we choose what appears here, and what we are paid for, is set out in our editorial policy.